Cryoport Inc (CYRX) 1.61 $CYRX Cryoport Enters

New Post Public Reply Private Reply Replies (0) Message Board

Jun 17, 2016 at 10:14 PM

Cryoport Inc (CYRX) 1.61 $CYRX

Cryoport Enters Bio-Storage Market
PR Newswire - Wed Jun 15, 8:15AM CDT
Cryoport, Inc. (CYRX) ("Company"

, the world's leading cryogenic logistics company, today announced the launch of its bio-storage offering. The new offering is the result of a clear demand from Cryoport customers to complement its leading cryogenic logistics solutions with advanced storage and fulfillment capabilities. Cryoport Biostorage will support cryogenic storage, fulfillment, and transportation of all valuable and often irreplaceable temperature-sensitive biologic material, including clinical trial samples, vaccines, stem cells, regenerative therapies, bio-markers and immunotherapies.
CYRX: 1.61 (+0.10)

Cryoport Reminds Record Date Rights Holders for the Rights Offering to Submit all Subscriptions to Their Broker or Subscription Agent
PR Newswire - Fri Jun 10, 8:21AM CDT
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) (the "Company"

, the world's leading cryogenic logistics company, would like to remind its rights offering shareholders and warrant holders of record that they have the right, but not the obligation, to exercise their non-transferable basic subscription rights for $1.55 per common share, which allows its shareholders and warrant holders of record to acquire additional shares of common stock (the "rights offering"

.
CYRX: 1.61 (+0.10)

Cryoport Signs Strategic Agreement to Support Tissue Solutions Transportation of Human Cells and Cryopreserved Cell Lines
PR Newswire - Wed Jun 08, 7:00AM CDT
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"

announced today that its industry leading cryogenic logistics solutions, including cryogenic shipping, logistics support and chain of condition monitoring, are supporting Tissue Solutions ("Tissue Solutions"

as it transports products from their global network of more than 100 locations. Tissue Solutions is a leading supplier of human bio specimens to the pharmaceutical and biotech industries worldwide, specializing in the supply of high quality, ethically sourced human tissue and bio fluids for clinical trial programs.
CYRX: 1.61 (+0.10)

Worthington Industries Scales New 52-Week High of $39.75
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 1:47PM CDT
Shares of Worthington Industries Inc. (WOR) touched a new 52-week high of $39.75 yesterday before retracing to end the day at $39.61.
CYRX: 1.61 (+0.10), KALU: 87.50 (+0.42), WOR: 39.11 (-0.16), X: 17.98 (+0.11)

Cryoport Reminds All Interested Parties That Today is the Final Day to Become a Rights Offering Record Date Holder
PR Newswire - Wed May 25, 8:15AM CDT
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) (the "Company"

, the world's leading cryogenic logistics company,would like to remind the investment community that an investor must own CYRX, CYRXW or any other Cryoport warrants by 4:00 PM ET on Wednesday, May 25, 2016 in order to be considered a record date holder for purposes of the Rights Offering.
CYRX: 1.61 (+0.10)

Cryoport to Provide Cold Chain Logistics Support for International Stem Cell Corporation's Phase I Clinical Trial for the Treatment of Parkinson's Disease
PR Newswire - Mon May 23, 7:00AM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, the world's leading cryogenic logistics company for the life sciences industry, today announced that it will provide global logistics support to International Stem Cell Corporation's (OTCQB: ISCO) ("ISCO"

for its Phase I clinical trial in Australia for the treatment of moderate to severe Parkinson's disease. ISCO commenced patient enrollment for the study earlier this month.
CYRX: 1.61 (+0.10)

Cryoport Announces Share Pricing Period and Record Date for Shareholder and Warrant Holder Rights Offering
PR Newswire - Mon May 16, 7:49AM CDT
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"

, the world's leading cryogenic logistics company, announced today the pricing period and record date for its rights offering.
CYRX: 1.61 (+0.10)

Cryoport Agreement with Cryo Store BV Expands European Presence for its Best-in-Class Cryogenic Logistics Solutions
PR Newswire - Fri May 06, 8:15AM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, the world's leading cryogenic logistics company, today announced that Cryo Store BV ("Cryo Store"

, a European biostorage company, will utilize Cryoport's cryogenic logistics solutions to better serve the logistics needs of life sciences customers. Cryo Store provides storage and distribution services for temperature-controlled goods to biotechnology and pharmaceutical companies in Europe.
CYRX: 1.61 (+0.10)

Cryoport Files S-1 Registration Statement for Rights Offering
PR Newswire - Fri Apr 29, 12:43PM CDT
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"

, the world's leading cryogenic logistics company, announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC"

for a rights offering to its shareholders and warrant holders of record.
CYRX: 1.61 (+0.10)

Cryoport Signs Strategic Partnership Deal With Worthington Industries
PR Newswire - Wed Apr 13, 7:00AM CDT
Cryoport, Inc. (NASDAQ: CYRX), the world's leading cryogenic logistics company, announced today that it has entered into a strategic partnership with Worthington Industries (NYSE: WOR), maker of cryogenic storage vessels and equipment. Through this partnership, Worthington's CryoScience by Taylor Wharton business will design and manufacture biostorage and logistics equipment for use in Cryoport's life sciences cryogenic logistics solutions.
CYRX: 1.61 (+0.10), WOR: 39.11 (-0.16)

Cryoport Chosen to Provide Cold Chain Logistics Support to ProteoGenex
PR Newswire - Mon Apr 04, 8:19AM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, the world's leading cryogenic logistics company, today announced it is providing cryogenic logistics solutions that support ProteoGenex, Inc.'s ("ProteoGenex"

shipping of biological specimens, including PBMCs, BMMCs, frozen tissue, OCT-embedded tissue, blood serum, blood plasma, whole blood, RNA/DNA, and other bio-fluids.
CYRX: 1.61 (+0.10)

UPS Adds Cryogenic Shipping to Its Temperature-Sensitive Portfolio In Europe
PR Newswire - Tue Mar 15, 7:00AM CDT
UPS (NYSE: UPS) announced the launch of UPS Temperature True® Cryo in Europe, providing healthcare customers access to end-to-end product protection and capability to ship parcels in a cryogenic environment. The service includes real-time tracking and intervention, which, when combined with UPS's risk mitigation solutions and global network of control towers, will provide complete visibility for shipments at every stage of the supply chain journey.
CYRX: 1.61 (+0.10), UPS: 105.02 (+0.81)

Cryoport Supports ImmunoCellular Therapeutics' 120-Site Phase III Clinical Trial With Cold Chain Logistics
PR Newswire - Thu Mar 03, 7:00AM CST
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, the world's leading cryogenic logistics company, today announced that it will be supporting the cryogenic logistics requirements of ImmunoCellular Therapeutics' (NYSE MKT: IMUC) ("ImmunoCellular"

registrational Phase III glioblastoma clinical trial across 120 sites in North America and Europe. This clinical trial is designed to evaluate the safety and efficacy of ImmunoCellular's lead product candidate ICT-107, a patient-derived dendritic cell-based immunotherapy.
CYRX: 1.61 (+0.10), IMUC: 0.24 (-0.01)

Cryoport to Present at the Source Capital Group's 2016 Disruptive Growth & Healthcare Conference
PR Newswire - Thu Feb 04, 7:30AM CST
Cryoport, Inc. (NASDAQ: CYRX), the world's leading cryogenic logistics company, today announced that Jerrell Shelton, Chief Executive Officer of Cryoport, Inc, will present at the Source Capital Group's 2016 Disruptive Growth & Healthcare Conference to be held at the Convene, 730 Third Avenue in New York City on Wednesday, February 10, 2016 at 10:15am ET.
CYRX: 1.61 (+0.10)

Cryoport to Report Third Quarter Fiscal 2016 Financial Results on February 8th
PR Newswire - Tue Feb 02, 7:00AM CST
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, today announced that the Company will release financial results for the third quarter fiscal year 2016 ended December 31, 2015 on February 8, 2016 before the market opens.
CYRX: 1.61 (+0.10)

Cryoport Introduces Its Advanced Cryogenic Logistics Solutions for IVF to the Cambodia and Czech Republic Markets
PR Newswire - Tue Jan 26, 7:30AM CST
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, the leading global cryogenic logistics company for the life sciences industry, today announced the geographic expansion of its Reproductive Medicine (IVF) shipping and logistics solutions to include Cambodia and the Czech Republic.
CYRX: 1.61 (+0.10)

Cryoport Is Selected By Morphotek to Manage Cold Chain Logistics
BusinessWire - Wed Jan 13, 12:00PM CST
Cryoport, Inc. (NASDAQ:CYRX), ("Company"

, the world's leading cryogenic logistics company, and Morphotek(R) announced that Cryoport is providing end-to-end cold chain logistics support for shipments of Morphotek's research and development materials.
CYRX: 1.61 (+0.10)

Cryoport Announces Opening of New US Headquarters
PR Newswire - Tue Dec 08, 7:30AM CST
Cryoport, Inc. (NASDAQ: CYRX) ("Company"

, the world's leading cryogenic logistics company, today announced the opening of its new US headquarters in Irvine, CA. The purpose-built facility supports the Company's long-term expansion plans for its logistics operations and client-demanded scalability.
CYRX: 1.61 (+0.10)

Cryoport Revenues Climb 74% for the Second Quarter of Fiscal Year 2016
PR Newswire - Mon Nov 16, 7:00AM CST
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"

today announced financial results for the three and six month periods ended September 30, 2015.
CYRX: 1.61 (+0.10)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

New CEO at Simpli.fi: Sean McCaffrey Takes Charge

A New Captain at Simpli.fi's Helm In the fast-paced world of digital advertising, Simpli.fi isn't just sitting on the sidelines. They've gone and snagged Sean McCaffrey as their new CEO. Now, for those who remember GSTV's rise to 30,000 locations under McCaffrey, this appointment carries some serious weight. McCaffrey's Track Record: Setting the Pace McCaffrey's no...

Security Leadership Faces Unseen Identity Risks

Rocky Road in Identity Security Catch this: you're a security honcho, thinking you've forked over enough dough to lock down human and machine identities. But now, it turns out, most of your kind still don't have a full handle on who or what is poking around your systems. Talk about a wrench in the gears. This latest report from Oak drags the reality into the limelight:...

Roof Inspections: Richmond's Key to Home Longevity

Inspect, Protect, and Forget Your Worries Homeowners in the Greater Richmond area wisely take to heart the old saying: an ounce of prevention is worth a pound of cure. But let's cut through the noise for a moment and zero in on a foundational truth: regular roof inspections are not a luxury—they're an absolute must. Roofing expert Seth Brown, from BNH Roofing, makes it...

OppFi Readies Q3 Earnings; Investors Eye Financials

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

King City Gardens Debuts Third Dispensary in Cincinnati

Every corner of Cincinnati’s cannabis scene just got a little busier with King City Gardens opening up shop in Colerain Township. This move marks their third Garden Dispensary in Greater Cincinnati. It’s not just about adding another location, though. It’s King City’s way of cementing their local roots deeper into the city’s soil, rolling out a mix of...

Teen Driver Safety Week: Practical Tips for Parents

The Growing Pains of Teen Driving Getting a driver's license is exciting for teens, but let's face it—the road is no playground. In 2024, a staggering 2,320 lives were lost in the U.S. due to crashes with teen drivers at the wheel. These stats aren’t just numbers—they’re grim reminders that safety isn’t a given for young drivers. Amidst this backdrop, the...

Netcapital Faces Securities Fraud Claims: Key Investor Notes

Netcapital Under Fire: The Suit Unfolds You ever see a stock go through such highs and lows that you wish you had popcorn on standby? Well, that's where Netcapital Inc. (NASDAQ: NCPL) is sitting right now, in the midst of a class action lawsuit that's got investors' heads spinning. The accusations are serious: false and misleading statements about revenues that seem to...

Tenet® Beef: Revolutionizing Tenderness in America's Steaks

Cracking the Code: A Genetic Leap in Beef Tenderness Well, buckle up, folks, because Callipyge Genetics is shaking things up in the beef aisle with their genomic breakthrough, Tenet®. It's about time we see some real innovation in an industry that's, let's face it, been slow to evolve. This isn't just a flash in the pan—a bit of DNA parsing has uncovered how to...

Nest Health Appoints Peter Morrison for Multistate Expansion

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

LBT Unveils Game-Changing Cyclotron for Medical Advances

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...